Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a scented massage boost brain function in ICU patients?

NCT ID NCT07593430

Symptom relief Sponsor: Nigde Omer Halisdemir University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether a daily aromatherapy massage, combined with a sensory stimulation program, can improve cognitive function in intensive care patients with brain injuries. Sixty adults on ventilators or oxygen will be randomly assigned to receive the treatment from a family member, a nurse, or standard care. The goal is to see if this gentle approach can help patients become more aware and responsive.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
aromatherapy massage with orange, patchouli, and rosemary oils
What this could lead to
If it works, this could offer a simple, drug-free way to help ICU patients regain awareness and shorten their hospital stay.
What could go wrong
This is a small, early-stage study with only 60 people. It is not yet recruiting, so results are unknown. The effect may be small or no different from standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with acute brain injury, * Glasgow Coma Score (GCS) between 6 and 12, * Intubated or monitored on oxygen, * 18 years of age or older, * Between 24 and 48 hours after hemodynamic vital signs stabilized and without a history of delirium, * Patients without a history of diseases that increase the risk of odor sensitivity, such as epilepsy or asthma, Exclusion Criteria: * Glasgow Coma Score (GCS) below 6, * Hemodynamic instability, * Continuously using neuromuscular blocking agents during the study, * Changes in treatment schedule during the study, * History of diseases that increase the risk of odor sensitivity, such as epilepsy or asthma,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute brain injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain injury cerebrovascular disorder injury lung disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebro vascular disease Cognitive sensory perception level In unconscious patients Lung disaases Trauma patients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.